Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Urologic Oncology|December 31, 2017
Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysisSolomon L Woldu, Bo Ci, Ryan C Hutchinson, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 19, 2022
Impact of exercise on physical health status in bladder cancer patientsMara Koelker, Khalid Alkhatib, Logan Briggs, et al.
European Urology Oncology|May 7, 2019
Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer OutcomesSolomon L Woldu, Joseph A Moore, Bo Ci, et al.
Urologic Oncology|May 21, 2020
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinomaNirmish Singla, Alana Christie, Yuval Freifeld, et al.
Urology|October 29, 2017
Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-based AnalysesSolomon L Woldu, Ahmet M Aydin, Ashwin V Rao, et al.
The Journal of Urology|February 11, 2018
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial CarcinomaEzra J Margolin, Justin T Matulay, Gen Li, et al.
Journal of Endourology|May 22, 2026
Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular CancerZhiyu Qian, Kevin Zhangxu, Christopher J Magnani, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Clinical and genomic profiling of early-onset bladder cancer identifies key alterations and therapeutic targetsChristopher J Magnani, Vincent D D'Andrea, Guilherme Garcia Barros, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/DocetaxelKendrick Yim, Matias Vergara, Jihyun Lee, et al.
Pageof 4